Literature DB >> 21242691

Longitudinal changes in cognition in Parkinson's disease with and without dementia.

David K Johnson1, James E Galvin.   

Abstract

BACKGROUND: The longitudinal cognitive course in Parkinson's disease (PD) with and without dementia remains undefined. We compared cross-sectional models of cognition in PD (both with and without dementia), Alzheimer's disease (AD), and nondemented aging and followed the participants over time.
METHOD: Previously validated models of cognitive performance in AD and nondemented aging were extended to individuals with PD (with dementia, n = 71; without dementia, n = 47). Confirmatory factor analysis and piecewise regression were used to compare the longitudinal course of participants with PD with 191 cognitively healthy subjects and 115 individuals with autopsy-confirmed AD.
RESULTS: A factor analytic model with one general factor and three specific factors (verbal memory, visuospatial memory, working memory) fit demented and nondemented PD. Longitudinal change indicated that individuals with PD with dementia declined significantly more rapidly on visuospatial and verbal memory tasks than AD alone. Cognitive declines across all factors in AD and PD dementia accelerated several years prior to clinical dementia diagnosis.
CONCLUSION: Both specific and global cognitive changes are witnessed in PD and AD. Longitudinal profiles of cognitive decline in PD and AD differed. PD with or without dementia has a core feature of longitudinal decline in visuospatial abilities.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21242691      PMCID: PMC3047760          DOI: 10.1159/000323570

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  34 in total

1.  Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementia.

Authors:  W P Goldman; J D Baty; V D Buckles; S Sahrmann; J C Morris
Journal:  Arch Neurol       Date:  1998-05

2.  Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results.

Authors:  D W McKeel; M J Ball; J L Price; D S Smith; J P Miller; L Berg; J C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  1993       Impact factor: 2.703

3.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

4.  Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of Alzheimer type.

Authors:  Daniel W McKeel; Joseph L Price; J Philip Miller; Elizabeth A Grant; Chengjie Xiong; Leonard Berg; John C Morris
Journal:  J Neuropathol Exp Neurol       Date:  2004-10       Impact factor: 3.685

Review 5.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

6.  What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study.

Authors:  A J Hughes; Y Ben-Shlomo; S E Daniel; A J Lees
Journal:  Neurology       Date:  1992-06       Impact factor: 9.910

7.  Individual differences in cross-sectional and 3-year longitudinal memory performance across the adult life span.

Authors:  E M Zelinski; M J Gilewski; K W Schaie
Journal:  Psychol Aging       Date:  1993-06

8.  Clock drawing in Alzheimer's disease. A novel measure of dementia severity.

Authors:  T Sunderland; J L Hill; A M Mellow; B A Lawlor; J Gundersheimer; P A Newhouse; J H Grafman
Journal:  J Am Geriatr Soc       Date:  1989-08       Impact factor: 5.562

9.  Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older.

Authors:  L Berg; D W McKeel; J P Miller; J Baty; J C Morris
Journal:  Arch Neurol       Date:  1993-04

10.  Validation of a short Orientation-Memory-Concentration Test of cognitive impairment.

Authors:  R Katzman; T Brown; P Fuld; A Peck; R Schechter; H Schimmel
Journal:  Am J Psychiatry       Date:  1983-06       Impact factor: 18.112

View more
  13 in total

1.  Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.

Authors:  G Stennis Watson; Brenna A Cholerton; Rachel G Gross; Daniel Weintraub; Cyrus P Zabetian; John Q Trojanowski; Thomas J Montine; Andrew Siderowf; James B Leverenz
Journal:  Alzheimers Dement       Date:  2012-11-16       Impact factor: 21.566

2.  Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?

Authors:  Jane E Alty; Jeremy Cosgrove; Stuart Jamieson; Stephen L Smith; Katherine L Possin
Journal:  Clin Neurol Neurosurg       Date:  2015-10-17       Impact factor: 1.876

Review 3.  The spectrum of cognitive impairment in Lewy body diseases.

Authors:  Jennifer G Goldman; Caroline Williams-Gray; Roger A Barker; John E Duda; James E Galvin
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

4.  Onset of Mild Cognitive Impairment in Parkinson Disease.

Authors:  David K Johnson; Zachary Langford; Mauricio Garnier-Villarreal; John C Morris; James E Galvin
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

Review 5.  The Differential Effects of Alzheimer's Disease and Lewy Body Pathology on Cognitive Performance: a Meta-analysis.

Authors:  Ashita S Gurnani; Brandon E Gavett
Journal:  Neuropsychol Rev       Date:  2016-11-22       Impact factor: 7.444

6.  Evaluation of mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Brenna A Cholerton; Cyrus P Zabetian; Jia Y Wan; Thomas J Montine; Joseph F Quinn; Ignacio F Mata; Kathryn A Chung; Amie Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; G Stennis Watson; Shu-Ching Hu; James B Leverenz; Karen L Edwards
Journal:  Mov Disord       Date:  2014-04-07       Impact factor: 10.338

7.  UPDATE ON DEMENTIA WITH LEWY BODIES.

Authors:  Stella Karantzoulis; James E Galvin
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2013-09-01

8.  Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; David A Bennett
Journal:  Neurobiol Aging       Date:  2013-10-09       Impact factor: 4.673

9.  Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice.

Authors:  Lilia Zurkovsky; Evgeny Bychkov; Elviche L Tsakem; Carley Siedlecki; Randy D Blakely; Eugenia V Gurevich
Journal:  Dis Model Mech       Date:  2012-08-03       Impact factor: 5.758

10.  Disease progression in patients with single, large-scale mitochondrial DNA deletions.

Authors:  John P Grady; Georgia Campbell; Thiloka Ratnaike; Emma L Blakely; Gavin Falkous; Victoria Nesbitt; Andrew M Schaefer; Richard J McNally; Grainne S Gorman; Robert W Taylor; Doug M Turnbull; Robert McFarland
Journal:  Brain       Date:  2013-11-25       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.